NO20011371L - Kjemokinreseptorantagonist og cyklosporin i kombinert terapi - Google Patents

Kjemokinreseptorantagonist og cyklosporin i kombinert terapi

Info

Publication number: NO20011371L
Authority: NO; Norway
Prior art keywords: cyclosporin; receptor antagonist; chemokine receptor; pharmaceutical composition; combined therapy
Prior art date: 1998-09-18

Application number

NO20011371A

Other languages

English (en)

Norwegian (no)

Other versions

NO20011371D0 (no

Inventor

Hermann-Joseph Grone

Peter J Nelson

Amanda Proudfoot

Timothy N C Wells

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-18

Filing date

2001-03-16

Publication date

2001-03-16

2001-03-16 Application filed by Applied Research Systems filed Critical Applied Research Systems

2001-03-16 Publication of NO20011371L publication Critical patent/NO20011371L/no

2001-03-16 Publication of NO20011371D0 publication Critical patent/NO20011371D0/no

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 3
229930105110 Cyclosporin A Natural products 0.000 title abstract 3
108010036949 Cyclosporine Proteins 0.000 title abstract 3
229960001265 ciclosporin Drugs 0.000 title abstract 3
229940122444 Chemokine receptor antagonist Drugs 0.000 title abstract 2
239000002559 chemokine receptor antagonist Substances 0.000 title abstract 2
229930182912 cyclosporin Natural products 0.000 title abstract 2
238000002648 combination therapy Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 3
108010023347 Met- RANTES Proteins 0.000 abstract 1
206010052779 Transplant rejections Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO20011371A 1998-09-18 2001-03-16 Kjemokinreseptorantagonist og cyklosporin i kombinert terapi NO20011371D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98117697A EP1000626A1 (de)	1998-09-18	1998-09-18	Kombination von chemokin-rezeptor antagonisten und cyclosporin zur therapie
PCT/EP1999/006844 WO2000016796A1 (en)	1998-09-18	1999-09-16	Chemokine receptor antagonist and cyclosporin in combined therapy

Publications (2)

Publication Number	Publication Date
NO20011371L true NO20011371L (no)	2001-03-16
NO20011371D0 NO20011371D0 (no)	2001-03-16

Family

ID=8232654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011371A NO20011371D0 (no)	1998-09-18	2001-03-16	Kjemokinreseptorantagonist og cyklosporin i kombinert terapi

Country Status (23)

Country	Link
US (1)	US6902728B1 (de)
EP (2)	EP1000626A1 (de)
JP (1)	JP2003519082A (de)
KR (1)	KR100613950B1 (de)
CN (1)	CN1177613C (de)
AR (1)	AR021810A1 (de)
AT (1)	ATE227582T1 (de)
AU (1)	AU766595B2 (de)
BR (1)	BR9913846A (de)
CA (1)	CA2344370A1 (de)
DE (1)	DE69903964T2 (de)
DK (1)	DK1113811T3 (de)
EA (1)	EA003181B1 (de)
EE (1)	EE04705B1 (de)
ES (1)	ES2186411T3 (de)
HK (1)	HK1041225B (de)
IL (2)	IL141899A0 (de)
NO (1)	NO20011371D0 (de)
PT (1)	PT1113811E (de)
SI (1)	SI1113811T1 (de)
UA (1)	UA60379C2 (de)
WO (1)	WO2000016796A1 (de)
ZA (1)	ZA200101909B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7259136B2 (en)	1999-04-30	2007-08-21	Amylin Pharmaceuticals, Inc.	Compositions and methods for treating peripheral vascular disease
US6740636B2 (en)	2000-07-31	2004-05-25	Schering Aktiengesellschaft	Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
LT5132B (lt)	2000-07-31	2004-05-25	Schering Aktiengesellschaft	Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti
MX2010001307A (es)	2007-08-02	2010-07-30	Novimmune Sa	Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos.
JP6733968B2 (ja) *	2015-08-31	2020-08-05	日立化成株式会社	腎移植後合併症を評価するための分子法
JP6624704B2 (ja)	2015-08-31	2019-12-25	日立化成株式会社	尿路上皮疾患の評価のための分子法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2207036A1 (en) *	1994-12-08	1996-06-13	Glaxo Group Limited	Rantes peptide and fragments and compositions comprising it for treatment of inflammation
AU712606B2 (en) *	1995-08-09	1999-11-11	Schering Corporation	Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
EP0927167A1 (de) *	1996-08-14	1999-07-07	Warner-Lambert Company	2-phenylbenzimidazol-derivate als mcp-1 antagonisten
WO1998006751A1 (en) *	1996-08-16	1998-02-19	Research Corporation Technologies, Inc.	Mcp-3, rantes and mip-1alpha receptor antagonists

1998
- 1998-09-18 EP EP98117697A patent/EP1000626A1/de not_active Withdrawn
1999
- 1999-09-16 CN CNB998111252A patent/CN1177613C/zh not_active Expired - Fee Related
- 1999-09-16 AT AT99948760T patent/ATE227582T1/de active
- 1999-09-16 SI SI9930157T patent/SI1113811T1/xx unknown
- 1999-09-16 DK DK99948760T patent/DK1113811T3/da active
- 1999-09-16 AR ARP990104655A patent/AR021810A1/es unknown
- 1999-09-16 ZA ZA200101909A patent/ZA200101909B/xx unknown
- 1999-09-16 ES ES99948760T patent/ES2186411T3/es not_active Expired - Lifetime
- 1999-09-16 DE DE69903964T patent/DE69903964T2/de not_active Expired - Lifetime
- 1999-09-16 EE EEP200100159A patent/EE04705B1/xx not_active IP Right Cessation
- 1999-09-16 EA EA200100366A patent/EA003181B1/ru not_active IP Right Cessation
- 1999-09-16 KR KR1020017003199A patent/KR100613950B1/ko not_active Expired - Fee Related
- 1999-09-16 PT PT99948760T patent/PT1113811E/pt unknown
- 1999-09-16 HK HK02103034.0A patent/HK1041225B/zh not_active IP Right Cessation
- 1999-09-16 EP EP99948760A patent/EP1113811B1/de not_active Expired - Lifetime
- 1999-09-16 IL IL141899??A patent/IL141899A0/xx active IP Right Grant
- 1999-09-16 BR BR9913846-8A patent/BR9913846A/pt not_active Application Discontinuation
- 1999-09-16 US US09/787,335 patent/US6902728B1/en not_active Expired - Fee Related
- 1999-09-16 AU AU61914/99A patent/AU766595B2/en not_active Ceased
- 1999-09-16 JP JP2000573757A patent/JP2003519082A/ja not_active Withdrawn
- 1999-09-16 UA UA2001042570A patent/UA60379C2/uk unknown
- 1999-09-16 CA CA002344370A patent/CA2344370A1/en not_active Abandoned
- 1999-09-16 WO PCT/EP1999/006844 patent/WO2000016796A1/en not_active Ceased
2001
- 2001-03-08 IL IL141899A patent/IL141899A/en not_active IP Right Cessation
- 2001-03-16 NO NO20011371A patent/NO20011371D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EA003181B1 (ru)	2003-02-27
DE69903964T2 (de)	2003-03-27
SI1113811T1 (en)	2003-04-30
CA2344370A1 (en)	2000-03-30
CN1177613C (zh)	2004-12-01
EP1000626A1 (de)	2000-05-17
ZA200101909B (en)	2001-09-11
IL141899A0 (en)	2002-03-10
WO2000016796A1 (en)	2000-03-30
JP2003519082A (ja)	2003-06-17
ES2186411T3 (es)	2003-05-01
HK1041225A1 (en)	2002-07-05
UA60379C2 (uk)	2003-10-15
IL141899A (en)	2007-12-03
AU6191499A (en)	2000-04-10
US6902728B1 (en)	2005-06-07
EP1113811B1 (de)	2002-11-13
HK1041225B (zh)	2005-04-22
KR100613950B1 (ko)	2006-08-18
KR20010075060A (ko)	2001-08-09
AR021810A1 (es)	2002-08-07
PT1113811E (pt)	2003-03-31
EE04705B1 (et)	2006-10-16
EA200100366A1 (ru)	2001-08-27
EP1113811A1 (de)	2001-07-11
EE200100159A (et)	2002-08-15
BR9913846A (pt)	2001-06-05
ATE227582T1 (de)	2002-11-15
DK1113811T3 (da)	2003-03-10
CN1319021A (zh)	2001-10-24
AU766595B2 (en)	2003-10-16
DE69903964D1 (en)	2002-12-19
NO20011371D0 (no)	2001-03-16

Similar Documents

Publication	Publication Date	Title
NZ515464A (en)	2004-02-27	Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
GB2357969A (en)	2001-07-11	Improvements in or relating to the treatment of lesions
GR3030924T3 (en)	1999-11-30	Selective system scan for multizone radiotelephone subscriber units.
CA2212537A1 (en)	1996-08-22	Therapeutic inhibitor of vascular smooth muscle cells
DE60031793D1 (de)	2006-12-21	Doxorubicin- und daunorubicin-enthaltende, zytotoxische mittel und deren therapeutische anwendung
DE59905954D1 (de)	2003-07-17	Dialkylfumarate zur behandlung von autoimmunerkrankungen
ATE333896T1 (de)	2006-08-15	Vaskularisierungsinhibitoren
Silberbauer et al.	1982	Racial differences in response to low‐dose captopril are abolished by the addition of hydrochlorothiazide.
IL158384A0 (en)	2004-05-12	Treatment or prophylaxis of insulin producing cell graft rejection
ATE152628T1 (de)	1997-05-15	Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DK0856312T3 (da)	1999-06-23	Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
HUS1900041I1 (hu)	2019-10-28	Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására
DE69824619D1 (de)	2004-07-22	Verfahren zur vorbeugung von durch zyklosporine oder tacrolimus verursachter nierenvergiftung
Frank et al.	1983	Clinical management: comparison of biobrane, porcine, and human allograft as biologic dressings for burn wounds
UA48986C2 (uk)	2002-09-16	Препарат для лікування серцево-судинних захворювань'кардіофіт"
EA200100366A1 (ru)	2001-08-27	Антагонист хемокинового рецептора и циклоспорин в комбинированной терапии
JP2003519082A5 (de)	2006-05-25
FR2811229B1 (fr)	2003-08-01	Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse
Hoffler et al.	1984	Nitrendipine in hypertension that is difficult to control
DE69931148D1 (de)	2006-06-08	Behandlung von hiv infektionen
Benmeir et al.	1991	Use of buried skin implants after recurrent failure of conventional skin grafting in a massive burn: the renewal of an old technique
Ichikawa et al.	1996	Three‐times‐daily monotherapy with tacrolimus (FK 506) in kidney transplantation
JPS5738715A (en)	1982-03-03	Medical composition having activity of prohibiting artery wall from thickening
BENNETT et al.	1969	The role of aggressive surgical treatment in the severely burned patient
HISANO et al.	1977	Experimental use of freeze-dried dura

Legal Events

Date	Code	Title	Description
2008-01-14	CREP	Change of representative	Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS
2009-10-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application